☰

Salud Bienestar

GlaxoSmithKline settles fraud charges for $3 billion


    WASHINGTON (Reuters) - GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay $3 billion to settle the largest case of healthcare fraud in U.S. history, according to court filings and prosecutors.

    The settlement includes $1 billion in criminal fines and $2 billion in civil fines in connection with the sale of the drug company's Paxil, Wellbutrin and Avandia products.

    (Reporting by David Ingram; Editing by Gerald E. McCormick)